NeuBase Therapeutics, Inc. Annual Research and Development Expense in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Research and Development Expense history and growth rate from 2010 to 2022.
  • NeuBase Therapeutics, Inc. Research and Development Expense for the quarter ending September 30, 2023 was $388K, a 92.9% decline year-over-year.
  • NeuBase Therapeutics, Inc. Research and Development Expense for the twelve months ending September 30, 2023 was $4.26M, a 80.1% decline year-over-year.
  • NeuBase Therapeutics, Inc. annual Research and Development Expense for 2022 was $21.4M, a 86.9% increase from 2021.
  • NeuBase Therapeutics, Inc. annual Research and Development Expense for 2021 was $11.5M, a 65.2% increase from 2020.
  • NeuBase Therapeutics, Inc. annual Research and Development Expense for 2020 was $6.95M, a 101% increase from 2019.
Research and Development Expense, Trailing 12 Months (USD)
Research and Development Expense, Annual (USD)
Research and Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $21.4M +$9.97M +86.9% Oct 1, 2021 Sep 30, 2022 10-K 2022-12-21
2021 $11.5M +$4.53M +65.2% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-21
2020 $6.95M +$3.5M +101% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-23
2019 $3.45M -$872K -20.2% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-23
2018 $4.32M -$13.1M -75.2% Oct 1, 2017 Sep 30, 2018 10-K 2019-01-03
2017 $17.4M +$946K +5.75% Oct 1, 2016 Sep 30, 2017 10-K 2019-01-03
2016 $16.5M +$7.68M +87.5% Oct 1, 2015 Sep 30, 2016 10-K 2017-12-15
2015 $8.78M +$4.41M +101% Oct 1, 2014 Sep 30, 2015 10-K 2016-12-22
2014 $4.37M +$1.62M +58.7% Oct 1, 2013 Sep 30, 2014 10-K 2016-12-22
2013 $2.75M +$1.13M +69.4% Oct 1, 2012 Sep 30, 2013 10-K 2015-12-14
2012 $1.63M +$1.1M +211% Oct 1, 2011 Sep 30, 2012 10-K 2014-12-22
2011 $522K +$219K +72.5% Oct 1, 2010 Sep 30, 2011 10-K 2013-01-09
2010 $303K Oct 1, 2009 Sep 30, 2010 10-K/A 2012-01-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.